Weekly nab-paclitaxel in combination with carboplatin as first-line therapy in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC).

Mark A. Socinski; Corey J. Langer; Isamu Okamoto; Jeremy K. Hon; Vera Hirsh; Shaker R. Dakhil; Ray D. Page; James M. Orsini; Hui Zhang; Markus F. Renschler

doi:10.1200/JCO.2012.30.15_SUPPL.7590

Weekly nab-paclitaxel in combination with carboplatin as first-line therapy in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC).

Mark A. Socinski
, Corey J. Langer
, Isamu Okamoto
, Jeremy K. Hon
, Vera Hirsh
, Shaker R. Dakhil
, Ray D. Page
, James M. Orsini
, Hui Zhang
, Markus F. Renschler

University of Pittsburgh
University of Pennsylvania
Kindai University
Clearview Cancer Institute, Huntsville, AL
McGill University
Cancer Center of Kansas, Wichita, KS
The Center for Cancer and Blood Disorders, Fort Worth, TX.
Essex Oncology of New Jersey PA, Belleville, NJ
Celgene

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	30
DOIs	https://doi.org/10.1200/JCO.2012.30.15_SUPPL.7590
State	Published - May 20 2012
Externally published	Yes

Disciplines

Medicine and Health Sciences
Oncology
Surgery
Internal Medicine

Access to Document

10.1200/JCO.2012.30.15_SUPPL.7590License: Unspecified

Cite this

Socinski, M. A., Langer, C. J., Okamoto, I., Hon, J. K., Hirsh, V., Dakhil, S. R., Page, R. D., Orsini, J. M., Zhang, H., & Renschler, M. F. (2012). Weekly nab-paclitaxel in combination with carboplatin as first-line therapy in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology, 30. https://doi.org/10.1200/JCO.2012.30.15_SUPPL.7590

@article{889447db36a347dd96ada4ea6a613aa9,

title = "Weekly nab-paclitaxel in combination with carboplatin as first-line therapy in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC).",

author = "Socinski, \{Mark A.\} and Langer, \{Corey J.\} and Isamu Okamoto and Hon, \{Jeremy K.\} and Vera Hirsh and Dakhil, \{Shaker R.\} and Page, \{Ray D.\} and Orsini, \{James M.\} and Hui Zhang and Renschler, \{Markus F.\}",

note = "7590 Background: The median age of advanced NSCLC pts in the US is 71 years; yetelderly pts (≥70 years) are generally undertreated, with only ≈30\% receiving systemic therapy. Hence, better, more tolerable therapeutic options are needed for this cohort.",

year = "2012",

month = may,

day = "20",

doi = "10.1200/JCO.2012.30.15\_SUPPL.7590",

language = "American English",

volume = "30",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - Weekly nab-paclitaxel in combination with carboplatin as first-line therapy in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC).

AU - Socinski, Mark A.

AU - Langer, Corey J.

AU - Okamoto, Isamu

AU - Hon, Jeremy K.

AU - Hirsh, Vera

AU - Dakhil, Shaker R.

AU - Page, Ray D.

AU - Orsini, James M.

AU - Zhang, Hui

AU - Renschler, Markus F.

N1 - 7590 Background: The median age of advanced NSCLC pts in the US is 71 years; yetelderly pts (≥70 years) are generally undertreated, with only ≈30% receiving systemic therapy. Hence, better, more tolerable therapeutic options are needed for this cohort.

PY - 2012/5/20

Y1 - 2012/5/20

UR - https://ascopubs.org/doi/abs/10.1200/jco.2012.30.15_suppl.7590

U2 - 10.1200/JCO.2012.30.15_SUPPL.7590

DO - 10.1200/JCO.2012.30.15_SUPPL.7590

M3 - Article

VL - 30

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Weekly nab-paclitaxel in combination with carboplatin as first-line therapy in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC).

Disciplines

Access to Document

Other files and links

Cite this